Nuformix plc Total Liabilities

Latest as of March 2026: GBX227.21K GBX ≈ $27.64 USD

Nuformix plc total liabilities. Based on the latest financial reports, Nuformix plc (NFX) has total liabilities worth GBX227.21K GBX (≈ $27.64 USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how many days can Nuformix plc fund operations to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Nuformix plc (2014–2025)

Total liabilities of Nuformix plc from 2014 to 2025. This chart illustrates how Nuformix plc's total liabilities have evolved over time, based on quarterly financial data.

Nuformix plc Competitors by Total Liabilities

The table below lists competitors of Nuformix plc ranked by their total liabilities.

Company	Country	Total Liabilities
Keras Resources PLC LSE:KRS	UK	GBX2.67 Million
Empire Metals Limited LSE:GEO	UK	GBX834.10K
CULLINAN METALS CORP. F:7KO	Germany	€854.49K
SpaceandPeople Plc LSE:SAL	UK	GBX6.79 Million
Union Jack Oil plc LSE:UJO	UK	GBX3.07 Million
Gfinity PLC LSE:GFIN	UK	GBX238.54K
KCR Residential Reit PLC LSE:KCR	UK	GBX14.66 Million
Holdco Nuvo Group D.G Ltd NASDAQ:NUVOQ	USA	$70.98 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Nuformix plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nuformix plc total assets.

Liquidity & Leverage Metrics

Nuformix plc Total Liabilities Ratios Explained

Nuformix plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.32	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nuformix plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nuformix plc (2014–2025)

The table below shows the annual total liabilities of Nuformix plc from 2014 to 2025.

Year	Total Liabilities	Change
2025-09-30	GBX263.92K ≈ $32.11	+3.51%
2024-09-30	GBX254.97K ≈ $31.02	+14.34%
2023-09-30	GBX222.99K ≈ $27.13	-18.48%
2023-03-31	GBX273.56K ≈ $33.28	+15.01%
2022-03-31	GBX237.86K ≈ $28.94	-26.73%
2021-03-31	GBX324.62K ≈ $39.50	-15.44%
2020-03-31	GBX383.91K ≈ $46.71	-53.15%
2019-03-31	GBX819.52K ≈ $99.71	+53.47%
2018-03-31	GBX534.00K ≈ $64.97	+168.05%
2017-03-31	GBX199.21K ≈ $24.24	+369.28%
2016-03-31	GBX42.45K ≈ $5.17	-39.15%
2015-12-31	GBX69.76K ≈ $8.49	-82.20%
2015-07-31	GBX391.86K ≈ $47.68	+36.41%
2014-07-31	GBX287.26K ≈ $34.95	--

About Nuformix plc

LSE:NFX UK Biotechnology

Market Cap

$33.98K

GBX279.24 Million GBX

Market Cap Rank

#31730 Global

#1231 in UK

Share Price

GBX0.11

Change (1 day)

+1.90%

52-Week Range

GBX0.10 - GBX0.43

All Time High

GBX13.75